D48.1
ICD-10Non-billable categoryNeoplasm of uncertain behavior of connctv/soft tiss
Official ICD-10-CM descriptor (FY2026)
Neoplasm of uncertain behavior of connective and other soft tissue
D48.1 is a category heading, not a billable code. CMS does not accept it on a claim; report one of the more specific codes beneath it.
Inclusion terms
- Neoplasm of uncertain behavior of connective tissue of ear
- Neoplasm of uncertain behavior of connective tissue of eyelid
- Stromal tumors of uncertain behavior of digestive system
Excludes1
Not coded here. An Excludes1 code should never be reported at the same time as the code above it.
- neoplasm of uncertain behavior of articular cartilage (D48.0)
- neoplasm of uncertain behavior of cartilage of larynx (D38.0)
- neoplasm of uncertain behavior of cartilage of nose (D38.5)
- neoplasm of uncertain behavior of connective tissue of breast (D48.6-)
ICD-10-CM FY2026 defines 2 codes beneath D48.1. See the ICD-10-CM index for what this site publishes.
Related codes in D48
- D48.0Neoplasm of uncertain behavior of bone/artic cartl
- D48.2Neoplm of uncrt behav of prph nerves and autonm nervous sys
- D48.3Neoplasm of uncertain behavior of retroperitoneum
- D48.4Neoplasm of uncertain behavior of peritoneum
- D48.5Neoplasm of uncertain behavior of skin
- D48.6Neoplasm of uncertain behavior of breastcategory
- D48.7Neoplasm of uncertain behavior of other specified sites
- D48.9Neoplasm of uncertain behavior, unspecified
Where this code sits
- Chapter
- 2. Neoplasms (C00-D49)
- Parent code
- D48
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
ICD-10-CM FY2026. Centers for Medicare & Medicaid Services (CMS) / National Center for Health Statistics (NCHS), “2026 ICD-10-CM Code Descriptions in Tabular Order” (icd10cm_order_2026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.